Strategies for improving hepatitis C treatment access in the U.S.

Results. Drug pricing is the most important barrier to access, encouraging restrictive authorization criteria from payers that in turn discourage providers from ...

Strategies for Improving Hepatitis C Treatment Access in...

While treatment eligibility criteria for HCV treatment are improving, many other barriers remain to achieving the scale-up needed to end the epidemic. Political ...

Strategies for Improving Hepatitis C Treatment Access in the United ...

While treatment eligibility criteria for HCV treatment are improving, many other barriers remain to achieving the scale-up needed to end the epidemic.

Health Care Provider Resources to Increase Hepatitis C Treatment

A CDC Vital Signs report calls for health care providers, insurers, policy makers, and public health professionals to improve access to ...

Programs and Initiatives | HHS.gov

Enhancing provider capacity for HCV testing and treatment: States developed new curricula, trained providers, and implemented pharmacist-led ...

Viral Hepatitis National Strategic Plan Overview - HHS.gov

The Viral Hepatitis Plan focuses on hepatitis A, hepatitis B, and hepatitis C—the three most common hepatitis viruses that have the most impact ...

Core Concepts - Addressing Structural Barriers to HCV Treatment

The lump-sum payment strategy allows pharmaceutical companies to increase their profit and guarantee revenue without limiting access to medications. Other ...

Opportunities for Enhanced Prevention and Control of Hepatitis C ...

To achieve adequate screening rates in a population, healthcare systems should adopt best practices to improve utilization of guideline-adherent ...

Medicaid Expansion and Restriction Policies for Hepatitis C Treatment

Initiation of DAA treatment was defined as the filling of any prescription drug corresponding to an HCV DAA using the US Food and Drug ...

(PDF) Strategies for Improving Hepatitis C Treatment Access in the ...

Context: Curative treatments for hepatitis C virus (HCV) can alter the course of a devastating epidemic, but high drug prices have contributed to ...

Addressing Structural Barriers to HCV Treatment - Core Concepts

A Novel Strategy for Increasing Access to Treatment for Hepatitis. C Virus Infection for Medicaid Beneficiaries. Ann Intern Med. 2018;169:118 ...

HCV Testing and Linkage to Care

Collaborate with specialists (eg, project ECHO-like models and telemedicine). Use simplified HCV treatment guidelines {Develop electronic health record ...

Viral Hepatitis Surveillance and Case Management - CDC

There is no vaccine to prevent hepatitis C. Therefore, the best way to prevent infection is by avoiding behaviors that can transmit the virus, such as sharing ...

Assessing the Effectiveness of Strategies in US Birth Cohort ...

Strategies including clinician education, electronic medical record alerts, reflex HCV RNA testing, point-of-care testing, multisite (outpatient ...

How to Improve HCV Treatment Access in the US - MDedge

Implementing strategies such as engaging in public and provider education and ensuring that treatment by primary care providers is reimbursed ...

When and in Whom to Initiate HCV Therapy | HCV Guidance

Successful hepatitis C treatment results in sustained virologic response (SVR), which is tantamount to virologic cure and, as such, is expected to benefit ...

Home | Hepatitis C: State of Medicaid Access

29 State Medicaid programs have removed i prior authorization on HCV treatment, one of the most stubborn barriers blocking access to care for millions of ...

We Must Do Better: Addressing HCV Treatment Barriers in Persons ...

Interventions to remove treatment barriers in the United States include harm reduction services, simplifying HCV testing algorithms, improved ...

MARYLAND HEPATITIS C STRATEGIC PLAN

Goal 3: Improve access to treatment and adherence services. Strategy 3.1: Improve linkage to timely and accessible hepatitis C care and adherence services.

Hepatitis C - World Health Organization (WHO)

Access to HCV treatment is improving but remains limited. Of the 50 million people living with HCV infection globally in 2022, an estimated 36% ...